Clinical Trials Directory

Trials / Unknown

UnknownNCT05311605

REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion

Status
Unknown
Phase
Study type
Observational
Enrollment
1,600 (estimated)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The aim of the study was to establish a clinical and advanced imaging database of acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China, and to investigate the predictors and potential mechanisms of futile recanalization after mechanical thrombectomy.

Detailed description

The time-window of mechanical thrombectomy for ischemic stroke has extended from 4.5 hours to 24 hours based on the results of the DAWN and DEFUSE 3 trials. However, evidence on the effectiveness and safety of mechanical thrombectomy within 24 hours in the real-world is insufficient. This is a multi-center, prospective, registry cohort study that acute ischemic stroke patients treated with mechanical thrombectomy due to large vessel occlusion of anterior circulation within 24 hours from stroke onset in China. A retrospective dataset was also build in these stroke centers for analysis. A total of 1600 patients with advanced imaging data were anticipated to be enrolled.

Conditions

Timeline

Start date
2023-02-23
Primary completion
2024-09-30
Completion
2024-12-31
First posted
2022-04-05
Last updated
2024-03-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05311605. Inclusion in this directory is not an endorsement.